Search This Blog

Tuesday, December 24, 2024

We'll learn about Ozempic's potential for Alzheimer's disease in 2025

 Ozempic and Wegovy are already transforming how we treat type 2 diabetes and obesity, and from next year another condition affecting millions of people worldwide might be added to the list: Alzheimer’s disease.

Two clinical trials investigating semaglutide, the drug in Ozempic and Wegovy, as a therapy for early Alzheimer’s are expected to conclude in 2025. If the results are positive, it could mark a breakthrough in treating this intractable condition.

https://www.newscientist.com/article/mg26435232-400-well-learn-about-ozempics-potential-for-alzheimers-disease-in-2025/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.